SureTrader
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, noretreat, TOB, sox040713, TheHound
Search This Board:
Last Post: 2/10/2016 11:46:18 PM - Followers: 688 - Board type: Free - Posts Today: 0

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Quarterly Report (10-q) 02/08/2016 04:03:50 PM
CTIX News: Amended Statement of Ownership (sc 13g/a) 01/27/2016 09:57:11 AM
CTIX News: Small Cap Stocks Are Heating up Again, Small Cap Street is Covering (OTCQB: ELTP),(OTCBB: AHIX), (OTCBB: AXXE), (OTCBB: CTIX) 01/26/2016 07:40:00 AM
CTIX News: Current Report Filing (8-k) 12/21/2015 08:19:27 AM
CTIX News: Statement of Changes in Beneficial Ownership (4) 12/18/2015 12:17:11 PM
PostSubject
#139558  Sticky Note 2-10-16 $CTIX ~ Cellceutix Corp. Due Diligence Report TheHound 02/10/16 01:02:36 PM
#139404  Sticky Note Cellceutix to Submit Special Protocol Assessment Request to GregChase 02/09/16 09:34:12 AM
#137845  Sticky Note Cellceutix Releases Data Used in Receiving FDA Orphan GregChase 01/22/16 12:06:04 PM
#133344  Sticky Note We are looking forward ... to our fiscal noretreat 12/14/15 02:58:59 PM
#132379  Sticky Note CTIX Potential Catalysts and Past Milestones sox040713 12/07/15 11:39:25 AM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#139653   Yep. I'm not holding my breath for it TheDane 02/10/16 10:18:53 PM
#139651   If Kevetrin works well against many cancers, then Phteven C 02/10/16 09:53:38 PM
#139650   Unsure about that. How long will B To infinity and beyond! 02/10/16 09:39:28 PM
#139649   I don't think you want to bring that loanranger 02/10/16 09:27:53 PM
#139648   Two words I want to hear soon ---> Matagordaville 02/10/16 09:23:29 PM
#139647   You didn't understand the post. loanranger 02/10/16 09:13:01 PM
#139646   Great! I've read about 28 pages so far. TheDane 02/10/16 09:01:09 PM
#139645   I don't have time to find links, but, KarinCA 02/10/16 08:53:00 PM
#139644   Dr. Frei was a nominee for a Nobel. BigKahuna 02/10/16 08:45:52 PM
#139643   "So, there exists a Nobel nominee AND a loanranger 02/10/16 08:26:27 PM
#139642   Thanks SLC. I was just about to renew TheHound 02/10/16 08:08:21 PM
#139641   I hadn't seen that. How is it in loanranger 02/10/16 08:07:56 PM
#139640   Now I'm convinced: loanranger 02/10/16 08:07:02 PM
#139639   And, it's now posted on the Cellceutix site. KarinCA 02/10/16 07:31:45 PM
#139638   In the past, LR has linked filings from KarinCA 02/10/16 07:12:22 PM
#139636   The company has stated the request would be Waverunner1 02/10/16 07:03:24 PM
#139635   yes it was time sent of 4:00 pm oldguy76 02/10/16 07:02:43 PM
#139634   From an FDA blog post - essentially FT slcimmuno 02/10/16 06:58:14 PM
#139633   "I was just pointing out that QIDP related loanranger 02/10/16 06:38:20 PM
#139632   I was quite happy when I clicked on KarinCA 02/10/16 06:34:52 PM
#139631   BK that is priceless. I think you should Whoops 02/10/16 06:26:59 PM
#139630   I'm not sure how you draw any conclusion Phteven C 02/10/16 06:18:23 PM
#139629   The entire document is full of interesting tidbits. KarinCA 02/10/16 06:17:25 PM
#139628   ANTIBIOTIC believer20 02/10/16 06:06:05 PM
#139627   this first in class anabiotic is that good believer20 02/10/16 06:04:18 PM
#139626   Hi LR. TheHound 02/10/16 06:02:26 PM
#139625   EDIT: I haven't seen the second filing from BigKahuna 02/10/16 05:48:36 PM
#139624   Easy there, cowboy. We'll have made plenty of Phteven C 02/10/16 05:36:16 PM
#139623   Certainly a thought. The US government could afford Phteven C 02/10/16 05:08:31 PM
#139621   Do you happen to have any non pacer KarinCA 02/10/16 04:36:32 PM
#139620   I would be very surprised if the Phase Waverunner1 02/10/16 04:25:49 PM
#139619   I was responding to a poster who asked loanranger 02/10/16 04:23:34 PM
#139618   2 of course, yes. To infinity and beyond! 02/10/16 04:21:32 PM
#139617   Or Ph 2/3 (wishful thinking) ;-) TheHound 02/10/16 04:18:56 PM
#139616   You mean to start a phase 2 frrol 02/10/16 04:16:14 PM
#139615   Such good news- NO delay for starting a To infinity and beyond! 02/10/16 04:10:26 PM
#139614   It's posted on Cellceutix site now: KarinCA 02/10/16 04:04:36 PM
#139613   Just received the email blast. incubus-now 02/10/16 04:04:33 PM
#139612   FDA APPROVES AND GUIDES CELLCEUTIX. Today's release once 58nout 02/10/16 04:02:42 PM
#139611   Boston Journal link works in the filing. KarinCA 02/10/16 04:01:19 PM
#139610   Thanks, Karin, et al. Nothing yet in ctix 02/10/16 03:58:23 PM
#139609   Good deal. I was just about to email TheHound 02/10/16 03:57:55 PM
#139607   Boston Journal link works in the filing. KarinCA 02/10/16 03:56:54 PM
#139606   Three times weekly dosing for Kevetrin Phase II KarinCA 02/10/16 03:54:27 PM
#139605   Nothing here. Maybe tomorrow. incubus-now 02/10/16 03:53:47 PM
#139604   Nope. TheHound 02/10/16 03:53:38 PM
#139603   Rosen has the ball... GregChase 02/10/16 03:53:35 PM
#139602   Looks like they submitted a dead link. Happens TheHound 02/10/16 03:52:40 PM
#139601   And Sullivan is practically holding his nose as frrol 02/10/16 03:47:58 PM
#139600   Not I... of the links posted here I KarinCA 02/10/16 03:45:07 PM
PostSubject